GR3002026T3 - Cephalosporin injection composition - Google Patents

Cephalosporin injection composition

Info

Publication number
GR3002026T3
GR3002026T3 GR91400137T GR910400137T GR3002026T3 GR 3002026 T3 GR3002026 T3 GR 3002026T3 GR 91400137 T GR91400137 T GR 91400137T GR 910400137 T GR910400137 T GR 910400137T GR 3002026 T3 GR3002026 T3 GR 3002026T3
Authority
GR
Greece
Prior art keywords
injection composition
cephalosporin
cephalosporin injection
quinuclindinio
methoxyiminoacetamido
Prior art date
Application number
GR91400137T
Other languages
English (en)
Inventor
Yasuo Ishibashi
Muneaki Matsuda
Kazuhide Ashizawa
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of GR3002026T3 publication Critical patent/GR3002026T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GR91400137T 1986-07-10 1991-05-30 Cephalosporin injection composition GR3002026T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61160746A JP2690009B2 (ja) 1986-07-10 1986-07-10 セフアロスポリン注射剤

Publications (1)

Publication Number Publication Date
GR3002026T3 true GR3002026T3 (en) 1992-12-30

Family

ID=15721560

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91400137T GR3002026T3 (en) 1986-07-10 1991-05-30 Cephalosporin injection composition

Country Status (8)

Country Link
US (1) US4822785A (el)
EP (1) EP0253329B1 (el)
JP (1) JP2690009B2 (el)
AT (1) ATE63814T1 (el)
CA (1) CA1293445C (el)
DE (1) DE3770355D1 (el)
ES (1) ES2039215T3 (el)
GR (1) GR3002026T3 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373000A (en) * 1985-12-26 1994-12-13 Eisai Co., Ltd. 7Beta-(thiadiazolyl)-2-iminoacetamido-3cephem compounds
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
CA2026516C (en) * 1989-09-30 1998-02-17 Yasuo Ishibashi Injectable preparations containing cephalosporin medicament
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
AU2003241675A1 (en) * 2002-06-21 2004-01-06 Shionogi And Co., Ltd. Medicinal cephem compound composition for injection
EP1656930A1 (en) * 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) * 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR101935186B1 (ko) 2014-09-04 2019-01-03 시오노기세야쿠 가부시키가이샤 카테콜기를 갖는 세팔로스포린류를 함유하는 제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2760484C2 (el) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
IL77458A (en) * 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor

Also Published As

Publication number Publication date
DE3770355D1 (de) 1991-07-04
EP0253329A3 (en) 1989-07-26
ATE63814T1 (de) 1991-06-15
EP0253329A2 (en) 1988-01-20
JP2690009B2 (ja) 1997-12-10
CA1293445C (en) 1991-12-24
ES2039215T3 (es) 1993-09-16
US4822785A (en) 1989-04-18
JPS6317827A (ja) 1988-01-25
EP0253329B1 (en) 1991-05-29

Similar Documents

Publication Publication Date Title
DE69015265T2 (de) Stabilisiertes Natriumperkarbonatmischung.
GR3002026T3 (en) Cephalosporin injection composition
EP0207045A3 (en) Stabilized galactomannan gum compositions
ES8303426A1 (es) Un procedimiento para la preparacion de un compuesto de cefalosporina.
SE8900173L (en) Temp. stable cephalosporin salts - as sulphuric, di-nitric, mono- or di-hydrochloric or orthophosphoric acid addn. salts
GB8617482D0 (en) Pharmaceutical composition
ATE73670T1 (de) Lysozyme hydrochlorid und dikaliumglycyrrhizinat enthaltende loesung.
PH20484A (en) Novel pyrimidine derivatives
ES2001338A6 (es) Un procedimiento para la preparacion de un solvato cristalino con dimetilformamida del acido 7-(d)-2-amino-2-(4-hidroxifenil) acetamido -3-(z)-1-propenil cef -3-em-4-carboxilico.
PH20699A (en) Salts of 2-keto-2h-1,2-benzisothiazole 1,1-dioxide as microbicides
EP0327358A3 (en) Ceftazidime dihydrochloride formic acid solvates
EP0276151A3 (en) Dissolved composition of ûbenzo-1,2,4-thiadiazine¨-1,1-dioxide
GR81580B (el)
GR3006357T3 (el)
ES8702918A1 (es) Un procedimiento para la preparacion de dihidrobromuro de acido (6r,7r)-7-((z)-2-(2-tritilaminotiazol-4-il)-2-(2-t-butiloxicarbonil-prop-2-oximino)acetamido)-3-(1piridiniometil)-3-cefem-4-carboxilico cristalino.
EP0292806A3 (en) Substituted vinyl cephalosporins, process for their preparation and their use as medicines
ZA867747B (en) Stabilization of interferons
PH20664A (en) Esters of 3-(1,2,3-thiadiazol-5-yl)thiomethyl)cephalosporin derivatives
DE3470783D1 (en) Attachment shank fo the bearing body of an air-cushion bearing
KR880000490B1 (en) 1-oxa-l-dethia-cephalosporin compounds and antibacterial agent comprising the same
EP0222577A3 (en) Crystalline cephalosporin monohydrate
EP0310259A3 (en) Eperisone as a hypotensive agent
JPS6110461B2 (el)
PT78554A (en) Oxytetracyclin solutions
FR2609490B3 (fr) Serrure avec palier pour poignee d'actionnement